UNICA IRIS Institutional Research Information System

ZUDDAS, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 107.500
NA - Nord America 11.395
AS - Asia 4.896
SA - Sud America 718
Continente sconosciuto - Info sul continente non disponibili 505
AF - Africa 108
OC - Oceania 42
Totale 125.164
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 103.225
US - Stati Uniti d'America 11.167
SG - Singapore 2.004
CN - Cina 1.570
NL - Olanda 1.175
UA - Ucraina 753
BR - Brasile 568
SE - Svezia 554
VN - Vietnam 447
FR - Francia 419
GB - Regno Unito 381
DE - Germania 359
FI - Finlandia 324
HK - Hong Kong 236
IN - India 133
CA - Canada 119
BD - Bangladesh 103
KR - Corea 79
RU - Federazione Russa 59
TR - Turchia 45
AR - Argentina 43
AU - Australia 41
MX - Messico 41
ZA - Sudafrica 41
IQ - Iraq 39
ES - Italia 32
AT - Austria 31
PL - Polonia 27
CO - Colombia 26
PK - Pakistan 26
CH - Svizzera 24
SA - Arabia Saudita 24
EC - Ecuador 23
ID - Indonesia 23
JP - Giappone 20
VE - Venezuela 20
PH - Filippine 19
AE - Emirati Arabi Uniti 17
BE - Belgio 17
MA - Marocco 17
CR - Costa Rica 16
IL - Israele 15
CL - Cile 14
MY - Malesia 14
UZ - Uzbekistan 14
DK - Danimarca 13
GR - Grecia 12
IE - Irlanda 12
IR - Iran 12
JM - Giamaica 12
JO - Giordania 11
NO - Norvegia 11
RO - Romania 11
BO - Bolivia 10
ET - Etiopia 9
HN - Honduras 9
LT - Lituania 9
EG - Egitto 8
KZ - Kazakistan 8
AL - Albania 7
DO - Repubblica Dominicana 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
KE - Kenya 6
PS - Palestinian Territory 6
PT - Portogallo 6
PY - Paraguay 6
BA - Bosnia-Erzegovina 5
TW - Taiwan 5
AZ - Azerbaigian 4
DZ - Algeria 4
GT - Guatemala 4
MD - Moldavia 4
NP - Nepal 4
PE - Perù 4
RS - Serbia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
EE - Estonia 3
EU - Europa 3
MU - Mauritius 3
NI - Nicaragua 3
PR - Porto Rico 3
SN - Senegal 3
UY - Uruguay 3
BY - Bielorussia 2
GN - Guinea 2
KN - Saint Kitts e Nevis 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
SM - San Marino 2
AO - Angola 1
Totale 124.638
Salva come PNG Salva come JPEG
Città #
Cagliari 94.988
Uta 5.293
Amsterdam 1.079
Singapore 1.033
Fairfield 921
Ashburn 904
Woodbridge 846
San Jose 613
Chandler 596
Houston 579
Boardman 576
Dallas 448
Ann Arbor 444
Jacksonville 393
Wilmington 385
Seattle 362
Nyköping 340
Beijing 297
Council Bluffs 296
Cambridge 293
Milan 262
Rome 260
Hong Kong 199
Helsinki 198
Los Angeles 193
Boston 156
Hefei 147
Lauterbourg 132
Santa Clara 130
Ho Chi Minh City 127
Nanjing 126
New York 124
The Dalles 122
Dearborn 114
Buffalo 85
Hanoi 82
Dong Ket 80
Shanghai 76
San Diego 66
Seoul 64
Redwood City 54
Padova 49
Shenyang 48
São Paulo 47
Guangzhou 46
Charleston 44
Frankfurt am Main 44
Columbus 43
Turin 39
Nanchang 38
Bari 37
Chicago 37
Changsha 36
Verona 36
Orem 35
Toronto 35
Washington 34
Nuremberg 33
Palermo 33
London 32
Atlanta 31
Naples 31
San Francisco 30
Florence 29
Sassari 29
Norwalk 28
Bologna 27
Brooklyn 27
Hebei 27
Jiaxing 26
Redondo Beach 26
Tianjin 25
Munich 24
Johannesburg 22
Stockholm 22
Orange 20
Pune 20
Sydney 20
Jinan 19
Phoenix 19
Warsaw 19
Zhengzhou 19
Baghdad 18
Denver 18
Genoa 17
Montreal 17
Rio de Janeiro 17
Tokyo 17
Auburn Hills 16
Da Nang 16
Hangzhou 16
Mexico City 16
Ningbo 16
Brescia 15
Catania 15
Venice 15
Chennai 14
Haiphong 14
Manchester 14
Mumbai 14
Totale 115.054
Salva come PNG Salva come JPEG
Nome #
Child and Adolescent Behavior Inventory (CABI): Standardization for age 6-17 years and first clinical application 2.130
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.885
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder 1.855
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 1.793
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.649
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder 1.627
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.608
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.568
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.522
Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials 1.508
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) 1.489
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives 1.468
Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents 1.468
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 1.426
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe 1.415
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.369
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 1.319
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.317
Corrigendum: Child and adolescent behavior inventory (CABI): A new instrument for epidemiological studies and pre-clinical evaluation 1.305
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.271
ADHD and hyperkinetic disorder 1.255
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group 1.252
Re-thinking treatment targets in child and adolescent psychiatry 1.216
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.151
CRS-R. Conners’ Rating Scales. Revised. Manuale 1.132
Psychosocial risk factors for suicidality in children and adolescents 1.094
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.072
null 1.045
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 1.031
A neurodevelopment approach for a transitional model of early onset schizophrenia 981
null 980
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies 969
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 939
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 890
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 882
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 869
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 824
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: A systematic review of head-to-head studies[ BMC Psychiatry. (2013)13, 237] 823
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 816
Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA Study 804
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial 773
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 764
null 754
null 750
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 741
Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply 734
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 734
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) 707
null 699
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study 696
null 689
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 689
null 675
null 665
null 658
Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD 635
The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions 634
null 632
Eziologia 628
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 612
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial 607
null 603
null 595
null 588
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 585
Association of Risk of Suicide Attempts With Methylphenidate Treatment 582
null 581
null 581
A crucial role for basic emotion awareness in the development of emotion regulation? 580
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 572
null 568
null 564
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 555
Management and treatment of attention-deficit/hyperactivity disorder 550
null 549
I Disturbi depressivi in età evolutiva 541
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and comorbid conditions 540
null 536
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents 536
Non-pharmacological interventions for Attention-Deficit/Hyperactivity Disorder: Systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments 526
The MTA at 8 523
null 519
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design 518
null 517
SRS Social Responsiveness Scale di John N. Constantino e Christian P. Grube 506
null 506
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review 505
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 504
European clinical guidelines for hyperkinetic disorder - first upgrade 503
null 501
null 501
null 497
null 491
null 477
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 469
null 467
Face and emotion recognition in children with ADHD and autism spectrum disorders: effects of methylphenidate 447
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder 445
null 444
Totale 86.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.144 0 518 324 892 763 432 371 602 813 872 740 817
2022/202314.499 1.096 1.876 1.615 1.101 1.067 1.151 670 1.949 962 856 1.497 659
2023/202416.961 829 681 632 1.058 1.953 2.626 2.791 1.014 844 1.224 1.784 1.525
2024/202533.367 5.755 8.871 5.369 4.342 2.223 1.915 1.670 232 420 1.380 581 609
2025/202610.186 678 333 998 776 851 908 1.366 817 741 1.378 805 535
2026/2027723 213 510 0 0 0 0 0 0 0 0 0 0
Totale 125.164